Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients

BACKGROUND: The 70-gene signature (70-GS, MammaPrint) test has been recommended by the main guidelines to evaluate prognosis and chemotherapy benefit of hormonal receptor positive human epidermal receptor 2 negative (HR + /Her2−) early breast cancer (BC). However, this expensive assay is not always...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Bo, Xu, Ying, Yao, Ru, Cao, Xi, Zhou, Xingtong, Hao, Zhixin, Zhang, Yanna, Wang, Changjun, Shen, Songjie, Luo, Yanwen, Zhu, Qingli, Ren, Xinyu, Kong, Lingyan, Zhou, Yidong, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637017/
https://www.ncbi.nlm.nih.gov/pubmed/37946210
http://dx.doi.org/10.1186/s12967-023-04523-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637017/
https://www.ncbi.nlm.nih.gov/pubmed/37946210
http://dx.doi.org/10.1186/s12967-023-04523-7

Ejemplares similares